BiomX
PHGE
14 hedge funds and large institutions have $1.14M invested in BiomX in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
40% more funds holding
Funds holding: 10 → 14 (+4)
0% less ownership
Funds ownership: 0.11% → 0.11% (-0%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
54% less capital invested
Capital invested by funds: $2.46M → $1.14M (-$1.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$46.1K |
| 2 |
Jane Street
New York
|
+$25.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$21.4K |
| 4 |
Walleye Capital
New York
|
+$9.05K |
| 5 |
Walleye Trading
New York
|
+$7.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$114K |
| 2 |
Renaissance Technologies
New York
|
-$8.03K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JJ
1
Johnson & Johnson
New Brunswick,
New Jersey
| $725K | – | – | – |
|
|
MI
2
MMCAP International
Grand Cayman,
Cayman Islands
| $233K | – | – | – |
|
|
RA
3
Royce & Associates
New York
| $54K | -$114K | -895 | -52% |
|
4
Millennium Management
New York
| $30K | +$5.99K | +47 | +11% |
|
|
VF
5
Virtu Financial
New York
| $23K | +$46.1K | +362 | New |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| $20K | – | – | – |
|
|
7
Jane Street
New York
| $20K | +$25.1K | +197 | +167% |
|
|
8
Citadel Advisors
Miami,
Florida
| $11K | +$21.4K | +168 | New |
|
|
9
Renaissance Technologies
New York
| $10K | -$8.03K | -63 | -28% |
|
|
10
Walleye Capital
New York
| $5K | +$9.05K | +71 | New |
|
|
11
Walleye Trading
New York
| $4K | +$7.01K | +55 | New |
|
12
BlackRock
New York
| $2K | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| $1K | -$4.59K | -36 | -64% |
|
|
O
14
OrbiMed
New York
| $957 | – | – | – |
|
PHGE Hedge Fund Activity: Q3 2022 in Review
14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2022, worth a combined $1.14M — down 54% from $2.46M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PHGE positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $46.1K. The largest seller was Royce & Associates, cutting an estimated $114K.
- 14 institutional investors held BiomX (PHGE) as of Q3 2022, up from 10 in Q2 2022.
- Funds reported $1.14M of BiomX stock for Q3 2022, down 54% quarter-over-quarter.
- 4 funds opened new BiomX positions in Q3 2022 and 0 closed out, a net change of +4 holders.
- The largest BiomX buyer in Q3 2022 was Virtu Financial, an estimated $46.1K added.
- The largest BiomX seller in Q3 2022 was Royce & Associates, an estimated $114K sold.
Based on aggregated 13F filings for Q3 2022.